Applied DNA Sciences Inc Free Cash Flow 2010-2025 | APDN
Applied DNA Sciences Inc free cash flow from 2010 to 2025. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Applied DNA Sciences Inc Annual Free Cash Flow |
| 2024 |
-14.12 |
| 2023 |
-6.25 |
| 2022 |
-9.47 |
| 2021 |
-15.94 |
| 2020 |
-12.21 |
| 2019 |
-6.93 |
| 2018 |
-7.18 |
| 2017 |
-7.63 |
| 2016 |
-10.56 |
| 2015 |
-8.82 |
| 2014 |
-8.74 |
| 2013 |
-9.09 |
| 2012 |
-4.12 |
| 2011 |
-3.85 |
| 2010 |
-2.46 |
| 2009 |
-2.47 |
| Applied DNA Sciences Inc Quarterly Free Cash Flow |
| 2025-03-31 |
-6.81 |
| 2024-12-31 |
-3.44 |
| 2024-09-30 |
-14.12 |
| 2024-06-30 |
-10.50 |
| 2024-03-31 |
-6.98 |
| 2023-12-31 |
-3.76 |
| 2023-09-30 |
-6.25 |
| 2023-06-30 |
-3.71 |
| 2023-03-31 |
-2.18 |
| 2022-12-31 |
-2.34 |
| 2022-09-30 |
-9.47 |
| 2022-06-30 |
-5.97 |
| 2022-03-31 |
-4.13 |
| 2021-12-31 |
-3.81 |
| 2021-09-30 |
-15.94 |
| 2021-06-30 |
-10.32 |
| 2021-03-31 |
-8.57 |
| 2020-12-31 |
-4.49 |
| 2020-09-30 |
-12.21 |
| 2020-06-30 |
-8.18 |
| 2020-03-31 |
-5.16 |
| 2019-12-31 |
-2.73 |
| 2019-09-30 |
-6.93 |
| 2019-06-30 |
-5.15 |
| 2019-03-31 |
-3.87 |
| 2018-12-31 |
-1.57 |
| 2018-09-30 |
-7.18 |
| 2018-06-30 |
-4.68 |
| 2018-03-31 |
-3.48 |
| 2017-12-31 |
-2.62 |
| 2017-09-30 |
-7.63 |
| 2017-06-30 |
-6.68 |
| 2017-03-31 |
-4.79 |
| 2016-12-31 |
-2.11 |
| 2016-09-30 |
-10.56 |
| 2016-06-30 |
-8.04 |
| 2016-03-31 |
-5.35 |
| 2015-12-31 |
-2.77 |
| 2015-09-30 |
-8.82 |
| 2015-06-30 |
-5.45 |
| 2015-03-31 |
-4.17 |
| 2014-12-31 |
-2.39 |
| 2014-09-30 |
-8.74 |
| 2014-06-30 |
-6.48 |
| 2014-03-31 |
-4.37 |
| 2013-12-31 |
-2.16 |
| 2013-09-30 |
-9.09 |
| 2013-06-30 |
-6.50 |
| 2013-03-31 |
-3.92 |
| 2012-12-31 |
-1.74 |
| 2012-09-30 |
-4.12 |
| 2012-06-30 |
-3.03 |
| 2012-03-31 |
-1.89 |
| 2011-12-31 |
-0.81 |
| 2011-09-30 |
-3.85 |
| 2011-06-30 |
-2.20 |
| 2011-03-31 |
-1.49 |
| 2010-12-31 |
-0.47 |
| 2010-09-30 |
-2.46 |
| 2010-06-30 |
-1.53 |
| 2010-03-31 |
-0.99 |
| 2009-12-31 |
-0.59 |
| 2009-09-30 |
-2.47 |
| 2009-06-30 |
-1.84 |
| 2009-03-31 |
-1.22 |
| Sector |
Industry |
Market Cap |
Revenue |
| Industrial Products |
Protection - Safety Equipment & Services |
$0.002B |
$0.003B |
|
Applied DNA Sciences, Inc. provides proprietary DNA-embedded biotechnology security solutions, using non-human DNA, that verify authenticity and protect corporate and government agencies from counterfeiting, fraud, piracy, product diversion, identity theft and unauthorized intrusion. They develop, market, and sub-license DNA security systems, supply-chain management systems and anti-counterfeit solutions. Applied DNA Sciences has an exclusive licensing and partnership agreement covering North America and Europe with Biowell Technology, Inc. of Taiwan.
|
